Intraosseous infusion devices Market Report 2026

The intraosseous infusion devices market size has grown strongly in recent years. It will grow from $3.39 billion in 2025 to $3.61 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increasing incidence of trauma and cardiac emergencies, demand for rapid vascular access in hospitals, adoption of manual io devices, growth in emergency medical services (ems), early use of intraosseous needles in pediatric care.

The intraosseous infusion devices market size is expected to see strong growth in the next few years. It will grow to $4.71 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising adoption of automated io devices, integration of io systems with hospital emergency protocols, expansion of io usage in ambulatory surgical centers, increased investment in training and simulation tools, development of multi-site intraosseous access solutions. Major trends in the forecast period include rapid emergency vascular access, pediatric and adult device adaptation, battery-powered and reusable drivers, single-use and disposable device adoption, training and simulation integration.

The growing incidence of trauma and emergency cases is expected to accelerate the growth of the intraosseous infusion devices market going forward. Trauma and emergency cases refer to medical situations requiring immediate or urgent care due to serious injuries, acute illnesses, or life-threatening conditions that require rapid assessment and intervention. Trauma and emergency cases are increasing as rising road traffic accidents, driven by higher vehicle density and high-speed travel, result in a greater number of severe injuries and emergency admissions. Intraosseous infusion devices enable fast and reliable access to the bloodstream when intravenous access is challenging in trauma or shock scenarios, ensuring the rapid delivery of fluids and critical medications, thereby facilitating timely and effective emergency care. For instance, in September 2025, according to the National Health Service, a UK-based government health agency, total accident and emergency attendances reached 27.4 million in 2024-25, representing a 4 percent increase compared with 2023-24. Therefore, the growing incidence of trauma and emergency cases is driving the growth of the intraosseous infusion devices market.

The growing hospital admissions are expected to advance the growth of the intraosseous infusion devices market going forward. Hospital admissions refer to the formal acceptance of patients into medical facilities for inpatient care and treatment. The rise in hospital admissions is primarily driven by the aging population, as older individuals require more frequent medical interventions and experience higher rates of chronic conditions that necessitate hospitalization. Increasing hospital admissions strengthen demand for intraosseous infusion devices, as these tools provide rapid vascular access during emergency situations and critical care scenarios when traditional intravenous access is difficult. For instance, in January 2025, according to the American Hospital Association, a US-based national organization representing hospitals and healthcare networks, total hospital admissions in the United States increased from 33,679,935 in 2022 to 34,426,650 in 2023, reflecting an increase of 746,715 admissions. Therefore, growing hospital admissions are reinforcing the growth of the intraosseous infusion devices market.

Key companies operating in the intraosseous infusion devices market are focusing on developing advanced systems, such as rapid vascular access devices, to enable faster and more reliable vascular access during life-threatening emergencies. A rapid vascular access device is a medical device that enables quick entry into the circulatory system to administer fluids, medications, or blood products during emergency and critical care scenarios. It is particularly used when traditional intravenous access is difficult, time-consuming, or impractical. For example, in October 2024, BD, a US-based medical technology company, launched the new BD Intraosseous Vascular Access System, an enhanced intraosseous access solution designed to establish vascular access within seconds for critical care situations. The system includes improved needle control, rapid insertion capability, and a user-friendly design to support clinicians in high-pressure environments, improving procedural efficiency and patient outcomes in emergency and acute care settings.

Major companies operating in the intraosseous infusion devices market are Cardinal Health Inc., Medline Industries Inc., Becton Dickinson and Company (BD), B Braun Melsungen AG, ZOLL Medical Corporation, Teleflex Incorporated, Cook Medical LLC, Shandong Weigao Group Co Ltd, Vygon SA, Argon Medical Devices Inc., Life Assist, Istem Medikal, SAM Medical Products, Implox Pty Ltd., BIOPSYBELL S R L (BPB Medica), Medax SRL, Troge Medical GmbH, Taizhou Kindly Medical Devices Co Ltd, PAVmed Inc., and Pyng Medical Corporation.

Tariffs have impacted the intraosseous infusion devices market by raising costs of imported powered and manual devices, needle sets, and stabilization kits. The most affected segments are automatic devices and battery-powered drivers, with regions like North America and Europe seeing higher price pressures due to reliance on foreign manufacturing. Positive impacts include increased demand for locally manufactured devices and accelerated innovation in domestic product lines, supporting regional supply chain resilience.

Intraosseous infusion devices are medical devices used to deliver fluids, blood products, and medications directly into the bone marrow when intravenous access is difficult or impossible. They provide rapid and reliable vascular access in emergency, trauma, and critical care situations. These devices are designed for quick insertion with minimal training and can be used in both pediatric and adult patients. They also ensure consistent drug absorption during shock or cardiac arrest.

The primary products of intraosseous infusion devices include bone injection gun (B.I.G), first access for shock and trauma 1 (FAST1), easy intraosseous (EZ-IO), first access for shock and trauma responder (FASTR), intraosseous (IO) needles, and other products. Bone injection gun (B.I.G) refers to a spring-loaded or pressure-driven device developed to quickly insert an intraosseous needle into the bone marrow for emergency vascular access when intravenous access is challenging or delayed. The technologies used include manual and automatic mechanisms, depending on ease of use and clinical setting. The routes of administration include the sternum, distal and proximal tibia, distal femur, calcaneus, and head of humerus. The end users of intraosseous infusion devices include emergency medical services (EMS), hospitals, ambulatory surgical centers, and cardiac care centers.

The intraosseous infusion devices market consists of sales of powered intraosseous devices, manual intraosseous devices, intraosseous access kits, needle sets, stabilization devices, extension tubing, and insertion adapters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The intraosseous infusion devices market research report is one of a series of new reports that provides intraosseous infusion devices market statistics, including intraosseous infusion devices industry global market size, regional shares, competitors with a intraosseous infusion devices market share, detailed intraosseous infusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the intraosseous infusion devices industry. This intraosseous infusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.